Details Basic Details Date Monday, August 26, 2019 Type Presentation Medical Product 13-valent pneumococcal vaccine (PCV13) PCV13 Health Outcome(s) Kawasaki disease Materials 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Kawasaki Disease Additional Information Information Host 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 2019 13-Valent Pneumococcal Conjugate Vaccination (PCV13) and Kawasaki Disease Contributors Presenter(s) Meghan A. Baker, Bethany Baer, Martin Kulldorff, Lauren Zichittella, Rebecca Reindel, Sandra DeLuccia, Hana Lipowicz, Katherine Freitas, Robert Jin, Katherine Yih